The FDA just issued an emergency use authorization (EUA) for bebtelovimab, a monoclonal antibody that "retains activity against Omicron.”
#Omicron #OmicronVariants #monoclonalantibodies
https://www.medpagetoday.com/infectiousdisease/covid19/97165
#Omicron #OmicronVariants #monoclonalantibodies
https://www.medpagetoday.com/infectiousdisease/covid19/97165
Medpage Today
FDA OKs New Monoclonal Antibody to Treat Omicron
Bebtelovimab has also shown activity against BA.2 subvariant, agency says